Microdosing a GLP-1 like semaglutide typically refers to using doses below the standard FDA-approved starting dose. Many patients use microdosing to maintain weight loss, reduce food noise, support blood sugar control, or explore other metabolic benefits while minimizing side effects.
Microdosing a GLP-1 (aka Ozempic, Wegovy, semaglutide, tirzepatide, zepbound, etc) is taking a lower than the lowest granular dose prescribed by the FDA for weight loss, but some people use it interchangeably when referring to one of the smaller doses on the dosing schedule. Microdosing is typically meant to maintain your current weight, but maximize the non-weight loss benefits of the medication – namely blood sugar management (aka reducing the spikes) and combatting inflammation.
At our practice, we have a special Microdosing program designed and developed by our founder and medical director, Dr. Evan Blum, MD. This program is built specifically to optimize the benefits of a dose of .2 mg or less. To book an appointment to begin microdosing, use the promo code MICRODOSE to get your first appointment and first five weeks of dosing/ medication for $299. Book here!
The microdosing program functions similar to our standard weight wellness program with unlimited access to the provider team. The program is $299 every five weeks for semaglutide doses under .2 mg and includes all medication and care.
The right way to microdose a GLP-1 is to take a subjectively small dose every 7 days. The reason we say subjectively small is because every single person is different. The amount of GLP-1 that is perfect for someone (even at a microdosing level) could be too little or too much for someone else.
When we say microdose, we also specifically think that the medication is meant to work and exist “behind the scenes.” Its impact on appetite is minimal. You may be making better choices and having slightly smaller portions, but on a microdose, you should not be eating significantly less.
For patients seeking additional weight loss, microdosing is generally less effective than standard therapeutic dosing. However, for patients who have already reached a healthy weight, microdosing may help maintain results while potentially providing ongoing metabolic benefits with fewer side effects.
The only correct way to microdose a GLP-1 is to take the medication every 7 days. Because the half-life of semaglutide is 7 days (165 hours), it reaches steady state in 4-5 weeks. This is when you are getting the most powerful dose of medication.
Some patients may experience improvements in cholesterol and other metabolic markers while taking semaglutide, although results vary significantly from person to person. In Wes Turner's personal microdosing journey, laboratory testing showed improvements in several health markers while maintaining a healthy weight. You can read his first entry here and recent update here.
His microdosing journey with Dr. Blum has also been featured by Men's Health in a story called Why Are Fit People Microdosing GLP-1s.
Not dosing every 7 days prevents you from hitting steady state and creates an environment of erratic side effects (both positive and negative), in addition to increasing the likelihood of negative side effects (think: nausea, GI issues, etc) as the medication works its way into and out of your system. Dosing on a schedule that is less frequent than a 7 day schedule creates a “sine wave” which attributes to this in addition to allowing us to to key in on the benefits of a specific dose (and its holistic benefits) rather than chasing a moving target.
To maximize low dose benefits, like combatting inflammation, a steady state is 100% necessary.
Microdosing the wrong way can create more internal chaos than harmony. With regard to dosing off of a 7 day schedule, only regulating blood sugar from time to time can make spikes and symptoms of a blood sugar spike more noticeable. A sine wave of medication due to the longer time between doses also can create inconsistent maintenance of weight, and any gain that comes as a result of inconsistent medication can lead to stress and fatigue. Inflammation benefits are also inconsistent when dosing is not done with regard to the half-life, but long term inflammation effects and inconsistency is not known.
Microdosing a GLP-1 has incredible benefits for maintaining a healthy weight and combatting inflammation. Inflammation can cause damage to healthy cells, tissues and organs, and may cause internal scarring, tissue death and damage to the DNA in previously healthy cells, in addition to being linked to chronic illnesses like cardiovascular disease, cancer, Alzheimer's disease, obesity, diabetes. If you’re at a healthy weight, but have a family history of some inflammation linked diseases or if you are looking to optimize your health and want to start with decreasing inflammation, microdosing a GLP-1 could be beneficial for you.
We were one of the first practices to launch a dedicated microdosing program because not every patient taking a GLP-1 is trying to lose weight. Some patients have already reached their goal weight and are looking to maintain their results while continuing to support metabolic health. Our team uses blood work, patient-reported outcomes, and regular provider follow-up to identify the lowest effective dose for each individual, creating a personalized approach to long-term GLP-1 care.
Microdosing semaglutide isn't simply about taking less medication, it's about finding the lowest effective dose that supports your individual goals. For some patients, that means maintaining weight loss. For others, it may mean reducing food noise, supporting blood sugar regulation, or continuing to experience metabolic benefits without the appetite suppression associated with higher doses.
The most important factor is consistency. Because semaglutide reaches a steady state after several weeks of weekly dosing, finding the right dose and schedule should always be done in partnership with a qualified medical provider.
If you're interested in exploring whether microdosing may be right for you, you can:
Our providers currently serve patients in North Carolina, South Carolina, Texas, New York, Arizona, Florida, Maryland, and additional states. We'd be happy to help you determine whether a microdosing approach aligns with your health goals.
